agilon health (NYSE:AGL) Stock Price Up 8.5% After Analyst Upgrade

Shares of agilon health, inc. (NYSE:AGL) rose 8.5% during mid-day trading on Thursday after Sanford C. Bernstein raised their price target on the stock from $2.50 to $3.15. Sanford C. Bernstein currently has a market perform rating on the stock. agilon health traded as high as $3.07 and last traded at $3.06. Approximately 2,185,717 shares changed hands during mid-day trading, a decline of 49% from the average daily volume of 4,326,648 shares. The stock had previously closed at $2.82.

Several other equities analysts have also recently issued reports on the company. Evercore ISI dropped their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Stifel Nicolaus dropped their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Barclays dropped their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Finally, Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a research report on Wednesday, October 2nd. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, agilon health currently has an average rating of “Hold” and an average target price of $4.03.

Insider Transactions at agilon health

In related news, Director John William Wulf bought 45,000 shares of agilon health stock in a transaction that occurred on Thursday, December 5th. The shares were purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now owns 206,133 shares in the company, valued at $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Diana Mckenzie bought 12,500 shares of agilon health stock in a transaction that occurred on Monday, November 25th. The stock was bought at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the purchase, the director now owns 51,319 shares in the company, valued at $117,007.32. This represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought 90,000 shares of company stock valued at $198,100 in the last quarter. 3.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. State Street Corp lifted its stake in agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after buying an additional 215,733 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after purchasing an additional 84,889 shares during the period. Citigroup Inc. lifted its stake in shares of agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after purchasing an additional 1,083,492 shares during the period. Finally, AQR Capital Management LLC lifted its stake in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the period.

agilon health Trading Up 5.1 %

The company has a market cap of $1.22 billion, a PE ratio of -3.15 and a beta of 0.53. The business has a 50 day simple moving average of $2.07 and a two-hundred day simple moving average of $3.67. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same period in the prior year, the company earned ($0.06) EPS. On average, analysts forecast that agilon health, inc. will post -0.59 EPS for the current fiscal year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.